Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase.
about
PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesisCytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liverBorn to run; the story of the PEPCK-Cmus mousePhosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism.What induces watts in WAT?Energy metabolism in the liverThe mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?Systemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats,Use of (2)H(2)O for estimating rates of gluconeogenesis: determination and correction of error due to transaldolase exchangeOverexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouseEffects of insulin and cytosolic redox state on glucose production pathways in the isolated perfused mouse liver measured by integrated 2H and 13C NMR.Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.2H2O incorporation into hepatic acetyl-CoA and de novo lipogenesis as measured by Krebs cycle-mediated 2H-enrichment of glutamate and glutamine.Rational design of ¹³C-labeling experiments for metabolic flux analysis in mammalian cellsDiminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice.Real-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-13C]dihydroxyacetoneBrain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance.The serum metabolite response to diet intervention with probiotic acidified milk in irritable bowel syndrome patients is indistinguishable from that of non-probiotic acidified milk by 1H NMR-based metabonomic analysisThe effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men.Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1.TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice.Metabolic Profiles of Obesity in American Indians: The Strong Heart Family Study.Metabolism of [U-13 C]glucose in human brain tumors in vivoLiver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation.Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.Phosphoenolpyruvate carboxykinase and glucose-6-phosphatase are required for steroidogenesis in testicular Leydig cellsInteraction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog.Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.PCB126-Induced Disruption in Gluconeogenesis and Fatty Acid Oxidation Precedes Fatty Liver in Male RatsHepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistanceInfluence of long (16L:8D) and short (8L:16D) photoperiods on blood metabolites and hepatic metabolism in Olive flounder, Paralichthys olivaceus.GCN2 regulates the CCAAT enhancer binding protein beta and hepatic gluconeogenesisAlterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction.Alterations of epinephrine-induced gluconeogenesis in aging.Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice.
P2860
Q24610431-0F8FD263-D864-41D3-9860-4BAEA92EF1B3Q24647278-64977558-4CCF-4C88-84E2-C744C5DF329CQ24652743-29570C51-F494-405B-BA3C-B0055C3D2864Q25257605-B5621883-87F7-408D-A3D8-675E7E7C33A3Q26744143-57C521A0-614F-45C0-8A35-B48A1A847860Q26996783-1027DFF1-3A03-4AEB-B3BB-31CC30B86ED3Q28396923-27DB8A00-C7B4-4412-88F9-026A42EF38DFQ29249076-2D41BAC7-C93C-4FE8-9BA5-DB9891916DA5Q30571857-C466F843-BFF0-4825-97E0-05E3BCADE484Q30655980-50B015A5-BA5F-44C3-B492-9870A6C5ACE9Q33227209-2B3B777C-F00E-4AEC-BE68-A16B060E32D3Q33869713-7D5F1D6C-E79E-47E1-BB34-A46DA79C91F3Q33910112-F9BED91D-5D5D-4956-9486-1EDFB65BE619Q34271662-9DB1EE73-A8B8-4555-8399-0EDD044E2367Q34617976-2E5D718C-8719-4C41-AA66-3252D486E236Q34774471-8A0D4FD5-E3A4-4B85-80DD-BD4622BCA455Q35187061-F48394BC-4275-400B-8018-AAEC9D6A81A0Q35571429-9F0F79C0-019A-4F4F-9F70-BFE028804A51Q35670842-10764E57-4828-4C5F-ADBC-9D390D1B799CQ35747829-BCDDAB3E-EF29-48BA-98CF-45998261E93FQ35754650-8BB1A8B8-E609-4DC6-AF4A-44015D2B845FQ35796844-94BED871-0BF6-4737-B47C-F0EACAE59C25Q36081758-C219DFEF-3D03-45D7-97C3-52A7BBBE540BQ36120642-1232D783-18C6-4558-81BE-172AE356E5C0Q36255938-C3205630-7C21-4AA4-B86F-BF88FC6DDCB5Q36335957-8634E953-C2DB-4DBD-BDE3-807D2D29CFEFQ36451928-07D94CD4-B2FD-4EFA-AB19-26864320A9BDQ36477271-E340CF85-924D-4C30-B19C-9B33B7F1BDB5Q36501828-7A0ABDAD-E49E-4745-A7B6-2999C133BD15Q36515889-2EFF3525-04E6-4432-B8E9-1B9B9EFFD325Q36583178-3D437EC8-8AB3-4CC1-AAF2-F39AD1A5FBC4Q36775647-AC907921-EDC3-4026-8206-58D49E6B44B4Q37000590-3148021F-8DDE-43D2-BECE-88A1D73AD8DEQ37004918-8443CAE7-D145-4287-B112-A454FD055197Q37014973-EA491C98-7395-44C2-BCC3-0956D3657ABBQ37053279-4418E1DB-73F4-44B1-9FBC-862310B8655FQ37234629-ECB70CE3-9BF9-4572-A009-4C51695B9CB4Q37239757-18325BC0-6EC8-49D9-9F9D-1CCF4727A11CQ37241677-6EC26464-E534-4C1A-8F17-47B247047662Q37428035-097BF582-6314-4781-BF37-7423CEC0ADBC
P2860
Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@ast
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@en
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@nl
type
label
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@ast
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@en
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@nl
prefLabel
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@ast
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@en
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@nl
P2093
P2860
P356
P1476
Impaired tricarboxylic acid cy ...... phoenolpyruvate carboxykinase.
@en
P2093
A Dean Sherry
Angela Milde
Charles Storey
Craig R Malloy
F Mark H Jeffrey
Matthew Merritt
Natasha Hausler
Seena Koshy
Shawn C Burgess
P2860
P304
48941-48949
P356
10.1074/JBC.M407120200
P407
P577
2004-09-03T00:00:00Z